Tribulus terrestris effect on satisfuction and sexual function

the effect of hydro alcohol extract of teribulus terisris on sexual function and satisfaction in post menopausal women

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016121131340N1

Enrollment

120

Registered

2017-07-23

Start date

2016-12-30

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sexual dys function. Either the prospect of sexual interaction produces sufficient fear or anxiety that sexual activity is avoided (sexual aversion) or sexual responses occur normally and orgasm is experienced but there is a lack of appropriate pleasure (lack of sexual enjoym

Interventions

Intervention 1: Intervention group 3:The Extract of HydroAlcolol of Teribulus Teristris, Syrup in 0.9 mg/dl Twice per day in 2 months. Intervention 2: Control group: syrups containing mannitol concent

Treatment - Drugs

Intervention group 3:The Extract of HydroAlcolol of Teribulus Teristris, Syrup in 0.9 mg/dl Twice per day in 2 months

Control group: syrups containing mannitol concentration of 0.5 Mg dl, twice a day for two months

Intervention group 1:The Extract of HydroAlcolol of Teribulus Teristris, Syrup in 0.5 mg/dl Twice per day in 2 months

Intervention group 2:The Extract of HydroAlcolol of Teribulus Teristris, Syrup in 0.7 mg/dl Twice per day in 2 months

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion Criteria:Postmenopausal women; reading and writing skills Exclusion Criteria:BMI 30 or higher; use of hormone therapy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Sexual Function. Timepoint: Before intervention,After 4 weeks and After 2 months. Method of measurement: FSFI Questionnaire.;Sexual Satisfaction. Timepoint: Before intervention,After 4 weeks and After 2 months. Method of measurement: Larenson Questionnaire.	—

Secondary

Measure	Time frame
_. Timepoint: _. Method of measurement: _.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMina shojaee

Ahvaz Jundishapur University of Medical Sciences

m.shojaee@ajums.ac.ir+98 61 5335 1538

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026